# PIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular Carcinoma

> **NCT06960954** · — · RECRUITING · sponsor: **Tanta University** · enrollment: 116 (estimated)

## Conditions studied

- Hepato Cellular Carcinoma (HCC)
- Portal Vein Tumour Thrombosis

## Interventions

- **DIAGNOSTIC_TEST:** Prothrombin induced by vitamin K absence II (PIVKA-II)

## Key facts

- **NCT ID:** NCT06960954
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-15
- **Primary completion:** 2025-12-15
- **Final completion:** 2025-12-31
- **Target enrollment:** 116 (ESTIMATED)
- **Last updated:** 2025-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06960954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06960954, "PIVKA-II for Predicting Portal Vein Thrombosis in Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06960954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*